Biodesix announces appointment of lawrence (lair) t. kennedy, jr. to board of directors

Boulder, colo.--( business wire )--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced the appointment of lawrence (lair) t. kennedy, jr. to the company's board of directors (board) and audit committee of the board effective january 3, 2023. mr. kennedy brings to biodesix more than 20 years of broad operating, corporate finance, company creation and investment experience with a specific focus in the healthcare industry.
BDSX Ratings Summary
BDSX Quant Ranking